New radiation therapy targets bone cancer cells directly
Disease control
Recruiting now
This study tests a new drug called LNTH-2403 in people with a type of bone cancer (osteosarcoma) that has returned or not responded to treatment. The drug delivers a small amount of radiation directly to cancer cells. The goal is to find the safest dose and see if it can control …
Phase: PHASE1, PHASE2 • Sponsor: Lantheus Medical Imaging • Aim: Disease control
Last updated May 17, 2026 02:07 UTC